Global Human Growth Hormone Drugs Market Size, Share, Trends and Forecast 2020-2026

Description

The global Human Growth Hormone Drugs market size is projected to reach US$ 324.2 million by 2026, from US$ 253.9 million in 2020, at a CAGR of 4.2% during 2021-2026.
This report focuses on Human Growth Hormone Drugs volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Human Growth Hormone Drugs market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, etc.
Global Human Growth Hormone Drugs Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Human Growth Hormone Drugs Market: Regional Analysis
The research report includes a detailed study of regions of North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, sales, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2015 to 2026. These analyses will help the reader to understand the potential worth of investment in a particular region.
Global Human Growth Hormone Drugs Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
Following are the segments covered by the report are:
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope - the Somatropin Biosimilar
Somatropin Biopartners
By Application:
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
Key Players:
The Key manufacturers that are operating in the global Human Growth Hormone Drugs market are:
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
Competitive Landscape
The analysts have provided a comprehensive analysis of the competitive landscape of the global Human Growth Hormone Drugs market with the company market structure and market share analysis of the top players. The innovative trends and developments, mergers and acquisitions, product portfolio, and new product innovation to provide a dashboard view of the market, ultimately providing the readers accurate measure of the current market developments, business strategies, and key financials.

TABLE OF CONTENT

1 Human Growth Hormone Drugs Market Overview
1.1 Product Overview and Scope of Human Growth Hormone Drugs
1.2 Human Growth Hormone Drugs Segment by Type
1.2.1 Global Human Growth Hormone Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Norditropin
1.2.3 Genotropin
1.2.4 Humatrope
1.2.5 Saizen
1.2.6 Omnitrope - the Somatropin Biosimilar
1.2.7 Somatropin Biopartners
1.3 Human Growth Hormone Drugs Segment by Application
1.3.1 Human Growth Hormone Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Prader-Willi Syndrome
1.3.3 Turner Syndrome
1.3.4 Short Stature Homeobox Gene
1.3.5 Small for Gestational Age
1.3.6 Chronic Renal Insufficiency
1.3.7 Short Bowel Syndrome
1.4 Global Human Growth Hormone Drugs Market Size Estimates and Forecasts
1.4.1 Global Human Growth Hormone Drugs Revenue 2015-2026
1.4.2 Global Human Growth Hormone Drugs Sales 2015-2026
1.4.3 Human Growth Hormone Drugs Market Size by Region: 2020 Versus 2026
1.5 Human Growth Hormone Drugs Industry
1.6 Human Growth Hormone Drugs Market Trends

2 Global Human Growth Hormone Drugs Market Competition by Manufacturers
2.1 Global Human Growth Hormone Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Human Growth Hormone Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Human Growth Hormone Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Human Growth Hormone Drugs Manufacturing Sites, Area Served, Product Type
2.5 Human Growth Hormone Drugs Market Competitive Situation and Trends
2.5.1 Human Growth Hormone Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Human Growth Hormone Drugs Players (Opinion Leaders)

3 Human Growth Hormone Drugs Retrospective Market Scenario by Region
3.1 Global Human Growth Hormone Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Human Growth Hormone Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Human Growth Hormone Drugs Market Facts & Figures by Country
3.3.1 North America Human Growth Hormone Drugs Sales by Country
3.3.2 North America Human Growth Hormone Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Human Growth Hormone Drugs Market Facts & Figures by Country
3.4.1 Europe Human Growth Hormone Drugs Sales by Country
3.4.2 Europe Human Growth Hormone Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Growth Hormone Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Human Growth Hormone Drugs Sales by Region
3.5.2 Asia Pacific Human Growth Hormone Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Human Growth Hormone Drugs Market Facts & Figures by Country
3.6.1 Latin America Human Growth Hormone Drugs Sales by Country
3.6.2 Latin America Human Growth Hormone Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Human Growth Hormone Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Growth Hormone Drugs Sales by Country
3.7.2 Middle East and Africa Human Growth Hormone Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Human Growth Hormone Drugs Historic Market Analysis by Type
4.1 Global Human Growth Hormone Drugs Sales Market Share by Type (2015-2020)
4.2 Global Human Growth Hormone Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Human Growth Hormone Drugs Price Market Share by Type (2015-2020)
4.4 Global Human Growth Hormone Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Global Human Growth Hormone Drugs Historic Market Analysis by Application
5.1 Global Human Growth Hormone Drugs Sales Market Share by Application (2015-2020)
5.2 Global Human Growth Hormone Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Human Growth Hormone Drugs Price by Application (2015-2020)

6 Company Profiles and Key Figures in Human Growth Hormone Drugs Business
6.1 Eli Lilly and Company (US)
6.1.1 Corporation Information
6.1.2 Eli Lilly and Company (US) Description, Business Overview and Total Revenue
6.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Eli Lilly and Company (US) Products Offered
6.1.5 Eli Lilly and Company (US) Recent Development
6.2 Ferring Holding SA (Switzerland)
6.2.1 Ferring Holding SA (Switzerland) Corporation Information
6.2.2 Ferring Holding SA (Switzerland) Description, Business Overview and Total Revenue
6.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Ferring Holding SA (Switzerland) Products Offered
6.2.5 Ferring Holding SA (Switzerland) Recent Development
6.3 Genentech, Inc. (US)
6.3.1 Genentech, Inc. (US) Corporation Information
6.3.2 Genentech, Inc. (US) Description, Business Overview and Total Revenue
6.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Genentech, Inc. (US) Products Offered
6.3.5 Genentech, Inc. (US) Recent Development
6.4 GeneScience Pharmaceuticals Co., Ltd. (China)
6.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Corporation Information
6.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Description, Business Overview and Total Revenue
6.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 GeneScience Pharmaceuticals Co., Ltd. (China) Products Offered
6.4.5 GeneScience Pharmaceuticals Co., Ltd. (China) Recent Development
6.5 Merck KgaA (Germany)
6.5.1 Merck KgaA (Germany) Corporation Information
6.5.2 Merck KgaA (Germany) Description, Business Overview and Total Revenue
6.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Merck KgaA (Germany) Products Offered
6.5.5 Merck KgaA (Germany) Recent Development
6.6 Novo Nordisk A/S (Denmark)
6.6.1 Novo Nordisk A/S (Denmark) Corporation Information
6.6.2 Novo Nordisk A/S (Denmark) Description, Business Overview and Total Revenue
6.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Novo Nordisk A/S (Denmark) Products Offered
6.6.5 Novo Nordisk A/S (Denmark) Recent Development
6.7 Pfizer, Inc. (US)
6.6.1 Pfizer, Inc. (US) Corporation Information
6.6.2 Pfizer, Inc. (US) Description, Business Overview and Total Revenue
6.6.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Pfizer, Inc. (US) Products Offered
6.7.5 Pfizer, Inc. (US) Recent Development
6.8 Sandoz International GmbH (Germany)
6.8.1 Sandoz International GmbH (Germany) Corporation Information
6.8.2 Sandoz International GmbH (Germany) Description, Business Overview and Total Revenue
6.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Sandoz International GmbH (Germany) Products Offered
6.8.5 Sandoz International GmbH (Germany) Recent Development

7 Human Growth Hormone Drugs Manufacturing Cost Analysis
7.1 Human Growth Hormone Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Growth Hormone Drugs
7.4 Human Growth Hormone Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Growth Hormone Drugs Distributors List
8.3 Human Growth Hormone Drugs Customers

9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 Global Market Forecast
10.1 Global Human Growth Hormone Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Growth Hormone Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Human Growth Hormone Drugs by Type (2021-2026)
10.2 Human Growth Hormone Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Growth Hormone Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Human Growth Hormone Drugs by Application (2021-2026)
10.3 Human Growth Hormone Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Growth Hormone Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Human Growth Hormone Drugs by Region (2021-2026)
10.4 North America Human Growth Hormone Drugs Estimates and Projections (2021-2026)
10.5 Europe Human Growth Hormone Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Human Growth Hormone Drugs Estimates and Projections (2021-2026)
10.7 Latin America Human Growth Hormone Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Human Growth Hormone Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample